These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21231862)

  • 1. Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery.
    Daniels SE; Spivey RJ; Singla S; Golf M; Clark FJ
    Curr Med Res Opin; 2011 Mar; 27(3):593-603. PubMed ID: 21231862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
    Daniels S; Casson E; Stegmann JU; Oh C; Okamoto A; Rauschkolb C; Upmalis D
    Curr Med Res Opin; 2009 Jun; 25(6):1551-61. PubMed ID: 19445652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions.
    Leibowitz MT; Zamora CA; Brzeczko AW; Stark JG
    Am J Ther; 2014; 21(2):99-105. PubMed ID: 22357166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery .
    Stegmann JU; Weber H; Steup A; Okamoto A; Upmalis D; Daniels S
    Curr Med Res Opin; 2008 Nov; 24(11):3185-96. PubMed ID: 18851776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the safety and efficacy of extended-release oxycodone/acetaminophen, for 14 days postsurgery.
    Singla N; Barrett T; Sisk L; Kostenbader K; Young J
    Curr Med Res Opin; 2014 Dec; 30(12):2571-8. PubMed ID: 25157951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone decreases oxycodone consumption following osteotomy of the first metatarsal bone: a randomized controlled trial in day surgery.
    Mattila K; Kontinen VK; Kalso E; Hynynen MJ
    Acta Anaesthesiol Scand; 2010 Mar; 54(3):268-76. PubMed ID: 19817718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain.
    Ashburn MA; Slevin KA; Messina J; Xie F
    Anesth Analg; 2011 Mar; 112(3):693-702. PubMed ID: 21304148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
    Yu SY;
    Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 3, randomized, double-blind comparison of analgesic efficacy and tolerability of Q8003 vs oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery.
    Richards P; Riff D; Kelen R; Stern W
    Pain Med; 2013 Aug; 14(8):1230-8. PubMed ID: 23802706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery.
    Stoker DG; Reber KR; Waltzman LS; Ernst C; Hamilton D; Gawarecki D; Mermelstein F; McNicol E; Wright C; Carr DB
    Pain Med; 2008; 9(1):3-12. PubMed ID: 18254761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo) in the treatment of postoperative pain.
    Richards P; Riff D; Kelen R; Stern W;
    J Opioid Manag; 2011; 7(3):217-28. PubMed ID: 21823552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain.
    Desjardins PJ; Black PM; Daniels S; Bird SR; Fitzgerald BJ; Petruschke RA; Tershakovec A; Chang DJ
    Curr Med Res Opin; 2004 Oct; 20(10):1523-37. PubMed ID: 15462686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.
    Binsfeld H; Szczepanski L; Waechter S; Richarz U; Sabatowski R
    Pain Pract; 2010; 10(5):404-15. PubMed ID: 20384968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.